+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Brain Imaging Modalities Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 181 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925067
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain imaging modalities market is responding to evolving clinical and operational objectives as healthcare providers seek advanced diagnostics and improved workflow efficiency. Senior decision-makers are increasingly focused on integrating innovative technologies and flexible solutions to enable accurate, timely care across diverse healthcare settings.

Market Snapshot: Growth in the Brain Imaging Modalities Market

The brain imaging modalities market is valued at USD 10.99 billion in 2024 and is expected to reach USD 11.71 billion in 2025, with a projected compound annual growth rate (CAGR) of 6.58%, reaching USD 18.32 billion by 2032. This sustained growth trajectory reflects the market’s response to ongoing clinical innovation, technology adoption, and evolving reimbursement models. As competitive pressures grow, industry stakeholders are strategically investing in enhanced imaging systems and streamlined workflows to improve both patient care and organizational resilience.

Scope & Segmentation: Comprehensive Market Coverage

This report provides senior executives with end-to-end insights into the entire brain imaging modalities ecosystem. The segmentation framework supports benchmarking and informs strategic choices by covering:

  • Modality: Covers computed tomography (cone beam, conventional), magnetic resonance imaging (angiography, diffusion, functional, structural), optical imaging (Fnirs, optical coherence tomography), positron emission tomography (amyloid, dopamine, FDG), single photon emission computed tomography (dopamine transporter), and ultrasound imaging (biomicroscopy, transcranial Doppler). These modalities are enabling more specialized and scalable clinical workflows, promoting ongoing technology innovation.
  • Application: Encompasses diagnostics for epilepsy, neurodegenerative diseases, brain injuries, tumor evaluation, and vascular assessments. Expands to research use cases, including brain mapping, neuroscience studies, drug development, and therapy monitoring, allowing organizations to support both clinical care and scientific advancement.
  • End User: Reflects implementation trends in academic institutions, ambulatory care, diagnostic centers, home healthcare organizations, hospitals, and research institutes in public and private sectors. This analysis aids in understanding technology deployment and operational requirements across diverse settings.
  • Geographic Regions: Examines the Americas, Europe/Middle East/Africa, and Asia Pacific, focusing on local market dynamics, infrastructure maturity, and policy influences shaping opportunity and risk profiles for market entrants and incumbents.
  • Corporate Analysis: Details Siemens Healthineers AG, General Electric Company, Koninklijke Philips N.V., Canon Inc., Hitachi Ltd., Fujifilm Holdings Corporation, Shimadzu Corporation, Neusoft Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., and Bruker Corporation. Senior leaders receive up-to-date competitive insights and innovation monitoring for effective strategy planning.

Key Takeaways: Strategic Insights for Decision-Makers

  • Continuous advancements in brain imaging hardware and analytics, including artificial intelligence, are raising expectations for diagnostic precision and operational effectiveness in neurological care.
  • Integration of multimodal platforms supports holistic approaches by aggregating patient data for deeper clinical insights and more comprehensive care pathways.
  • Portable and cloud-enabled imaging technologies are increasing access to diagnostics in decentralized environments, supporting remote monitoring and enabling home-based care strategies.
  • Regional diversification—through local manufacturing and cross-border research—helps organizations manage regulatory and supply chain risks while staying responsive to market fluctuations.
  • Collaboration among device manufacturers and data analytics experts accelerates product validation timelines and broadens available service portfolios, allowing stakeholders to remain agile in a shifting landscape.
  • Adopting modular system architectures and flexible procurement models strengthens organizations’ ability to address regulatory demands and adapt to changing clinical requirements.

Tariff Impact: Policy Changes and Supply Chain Adaptation

Following the introduction of US tariffs in 2025, companies in the brain imaging modalities market reevaluated sourcing strategies and diversified logistics networks to control costs. Expanding local vendor relationships and enhancing domestic production capacity have contributed to a shift toward modular systems, more strategic procurement processes, and increased regional self-sufficiency for essential supplies.

Methodology & Data Sources

This analysis is grounded in primary interviews with experts, detailed literature review, review of regulatory changes and patent activity, and structured quantitative forecasting. By integrating primary and secondary data sources, the report delivers robust recommendations for forward-looking strategies.

Why This Report Matters for Stakeholders

  • Enables senior leaders and investors to efficiently allocate resources to technology areas and regions with the highest growth and strategic potential.
  • Provides actionable recommendations that incorporate competitor, regulatory, and supply chain analysis to inform confident decision-making at the executive level.
  • Equips organizations to anticipate and mitigate procurement, compliance, and operational risks, strengthening business continuity and elevating standards in healthcare delivery.

Conclusion

Organizations that prioritize advanced imaging technologies, modular approaches, and regional adaptation can better respond to industry shifts. These strategic insights support the development of agile strategies suited to evolving healthcare market demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Emergence of ultra-high-field 7T and 11.7T MRI scanners enabling unprecedented brain resolution
5.2. Integration of artificial intelligence and deep learning algorithms for advanced neuroimaging analysis
5.3. Development of hybrid PET/MRI and SPECT/CT systems for comprehensive functional and structural mapping
5.4. Expansion of portable and point-of-care EEG and fNIRS devices for real-time neurological monitoring
5.5. Growing use of quantitative imaging biomarkers to assess neurodegenerative disease progression
5.6. Advancements in MR-guided focused ultrasound for non-invasive neuromodulation and targeted therapy
5.7. Adoption of cloud-based platforms and telemedicine solutions for remote brain imaging consultation
5.8. Innovation in radiopharmaceuticals and tracers for more specific molecular brain imaging diagnostics
5.9. Implementation of motion correction and accelerated imaging techniques to reduce scan time artifacts
5.10. Increased demand for functional connectivity mapping in psychiatric and cognitive disorder research
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brain Imaging Modalities Market, by Modality
8.1. Computed Tomography
8.1.1. Cone Beam
8.1.2. Conventional
8.2. Magnetic Resonance Imaging
8.2.1. Angiography
8.2.2. Diffusion
8.2.3. Functional
8.2.4. Structural
8.3. Optical Imaging
8.3.1. Fnirs
8.3.2. Optical Coherence Tomography
8.4. Positron Emission Tomography
8.4.1. Amyloid
8.4.2. Dopamine
8.4.3. Fdg
8.5. Single Photon Emission Computer Tomography
8.5.1. Dopamine Transporter
8.6. Ultrasound Imaging
8.6.1. Biomicroscopy
8.6.2. Transcranial Doppler
9. Brain Imaging Modalities Market, by Application
9.1. Diagnostics
9.1.1. Epilepsy
9.1.2. Neurodegenerative Disorders
9.1.3. Traumatic Brain Injury
9.1.4. Tumor Detection
9.1.5. Vascular Disease
9.2. Research
9.2.1. Brain Mapping
9.2.2. Neuroscience
9.2.2.1. Basic Research
9.2.2.2. Clinical Research
9.2.3. Pharmaceutical Development
9.3. Therapeutic Monitoring
9.3.1. Disease Progression Tracking
9.3.2. Surgical Monitoring
9.3.3. Treatment Response Assessment
10. Brain Imaging Modalities Market, by End User
10.1. Academic Institutions
10.1.1. Medical Schools
10.1.2. Universities
10.2. Ambulatory Care Facilities
10.3. Diagnostic Centers
10.4. Home Healthcare
10.5. Hospitals
10.6. Research Institutes
10.6.1. Government Labs
10.6.2. Private Labs
11. Brain Imaging Modalities Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Brain Imaging Modalities Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Brain Imaging Modalities Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Siemens Healthineers AG
14.3.2. General Electric Company
14.3.3. Koninklijke Philips N.V.
14.3.4. Canon Inc.
14.3.5. Hitachi Ltd.
14.3.6. Fujifilm Holdings Corporation
14.3.7. Shimadzu Corporation
14.3.8. Neusoft Medical Systems Co., Ltd.
14.3.9. Samsung Electronics Co., Ltd.
14.3.10. Bruker Corporation

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Brain Imaging Modalities market report include:
  • Siemens Healthineers AG
  • General Electric Company
  • Koninklijke Philips N.V.
  • Canon Inc.
  • Hitachi Ltd.
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Neusoft Medical Systems Co., Ltd.
  • Samsung Electronics Co., Ltd.
  • Bruker Corporation

Table Information